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Background: Magnetic	resonance	 imaging	 (MRI)	of	the	colonic	response	to	a	mac-
rogol challenge drink can be used to assess the mechanisms underlying severe con-
stipation.	We	measured	the	intrasubject	reproducibility	of	MRI	measures	of	colonic	













ICC overall (ascending colon =	0.65,	descending	colon	=	0.76,	P <	.001).
Conclusions: The	colonic	response	to	the	macrogol	stimulus	as	assessed	by	MRI	is	
heterogeneous	 but	 large	 compared	 to	 baseline,	with	moderate	 to	 good	 reproduc-
ibility,	making	 the	 test	 suitable	 to	study	potential	pathologies	underlying	GI	disor-
ders	such	as	constipation.	More	data	are	needed	to	better	define	the	normal	range	
for	 comparison	 with	 patient	 groups	 who	 may	 have	 both	 hypo-	 and	 hypermotile	
responses.
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on	quality	of	life2 and associated economic cost.3
The	 latest	 Rome	 Criteria	 (Rome	 IV)	 split	 primary	 constipation	
into	functional	constipation	(FC)	and	irritable	bowel	syndrome	with	
constipation	 (IBS-C),	 distinguished	 by	 the	 presence	 or	 absence	 of	
pain in association with bowel habit. These conditions may have dif-
ferent	underlying	mechanisms,	requiring	quite	different	treatments.	
Distinguishing these conditions in the clinic based mostly on patient 
report	 leads	 to	 trial	 and	 error	 treatments	which	may	 explain	why	
nearly	50%	of	patients	are	dissatisfied	with	their	treatment.4
A	novel	diagnostic	 test	using	magnetic	 resonance	 imaging	 (MRI)	
based on the consumption of a macrogol challenge drink has been 






It is currently unknown how reproducible the response of the 






The main aim of this study was to measure the intrasubject reproduc-
ibility	of	these	MRI	colon	function	measures	using	an	open-label	study	
design	in	a	group	of	healthy	volunteers.	A	secondary	aim	was	to	assess	
the feasibility of measuring the motor function of the descending colon 
(not	studied	in	previous	work)	since	abnormalities	of	distal	colon	function	







lenge drink can objectively assess colonic physiology 
(volume,	 fluid	 flow,	 wall	 motility,	 and	 water	 content).	
However,	the	reproducibility	of	these	responses	has	not	
been investigated.
• This study assessed the intrasubject reproducibility of 
these colonic responses in healthy volunteers using 
identical study protocols on two separate occasions.
•	 Colonic	water	 content,	 volumes,	 fluid	 flow,	 and	motil-
ity all consistently increased above baseline values 
post	stimulus.	The	colonic	water,	volume,	and	flow	data	
had	good	 intrasubject	 reproducibility.	AC	and	DC	mo-
tility were reasonably repeatable at baseline but the 
response to the challenge was variable between visits 
resulting in a lower ICC. This makes it a suitable test 
to	 study	potential	 pathologies	underlying	GI	disorders	
such as constipation.
F I G U R E  1  Schematic	of	the	study	day
     |  3 of 10WILKINSON-SMITH eT aL.
poly-ethylene	glycol	 and	electrolyte	 solution	 (Moviprep®,	Norgine	
Pharmaceuticals	Ltd).
The	 study	 was	 approved	 by	 the	 Ethics	 Committee	 of	 the	












unsuitability	 for	MRI	 scanning	 (such	 as	 pacemaker).	 Prior	 to	 each	
study	 visit,	 participants	were	 asked	 to	 complete	 the	 Talley	 bowel	
habit	questionnaire12 and screening diary to ensure they did not suf-
fer	from	recurrent	abdominal	pain	and	bowel	frequency	was	normal	





dietary supplements and alcohol for 24 hours prior to the study 
visit	and	caffeine	for	18	hours.	On	the	morning	of	the	scan,	partici-
pants arrived fasted (from 10.30 pm	the	night	before)	at	the	study	
centre.
After	 completing	 the	 daily	 eligibility	 questionnaire,	 partici-
pants	underwent	a	20	-	30	minute	MRI	baseline	scanning	session.	
Participants	 then	 drank	 10	 mL/kg	 of	 body	 weight	 (rounded	 to	
100	mL)	of	Moviprep®,	at	a	rate	of	2.5	mL/kg	per	15	minutes.	This	
was	based	on	previous	experience	 that	using	 fixed	doses	of	1000	
or	2000	mL	made	smaller	 subjects	unduly	nauseated	so	 that	 they	






and flatulence as absent =	0,	mild	=	1,	moderate	= 2 and severe = 3 




F I G U R E  2  A	+	B,	Pre-	and	post-stimulus	anatomical	3D	
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2.4 | MRI protocol
Imaging	was	carried	out	on	a	3.0T	Ingenia	wide-bore	scanner	(Philips,	
Best,	 The	 Netherlands)	 with	 a	 parallel	 imaging	 SENSE	 abdominal	
body	receiver	coil.	A	 range	of	MRI	sequences	were	used	to	 image	
the abdomen including:
1.	 Colonic	 regional	 and	 total	 volumes:	 a	 3D	 coronal	 dual-echo	
fast	 field	 echo	 sequence	 with	 mDIXON	 reconstruction.14
2.	 Bowel	Water	Content:	A	single	shot,	 coronal	 fast	 spin	echo	se-
quence	(rapid	acquisition	with	relaxation	enhancement,	RARE).
3.	 MRI	content	mixing	measurement:	A	single	10	mm	slice	cine	bTFE	
with tag lines 12 mm apart.
4.	 MRI	 wall	 movement	 measurement:	 Cine	 bTFE	 (balanced	 turbo	
field	echo).
Full	 sequence	 information	 is	 detailed	 in	 Table	 S4.	 Data	 were	
acquired	 on	 an	 expiration	 breath-hold	 with	 duration	 between	 18	
and	24	seconds	depending	on	the	sequence	(for	the	first	three	se-
quences)	 and	 monitored	 using	 a	 respiratory	 belt.	 The	 colon	 wall	
measurement	 sequence	was	 duration	10	minutes	with	 a	 temporal	
resolution	of	1	s	acquired	during	gentle	free	breathing.
TA B L E  1  Summary	data	of	all	MRI	endpoints	measured
Measurement Time point Visit 1 Visit 2
CoV CoV Intraclass correlation coefficient (ICC)
(Intrasubject) (Intersubject)
(Baseline and Maximum, Visit 1 vs 
Visit 2)
% % Lower Upper
Colon volume 
(mL)† 
Baseline 728	±	267 768	±	246 14 34 0.84 0.67 0.93 <0.001
Maximum 1226	±	336 1199 ± 242 11 24
(Base-max)a  P < .0001 P < .0001
Total water 
content	(mL)† 
Baseline 113 ±	63.3 108	± 49 34 51 0.93 0.84 0.97 <0.001
Maximum 1071	±	266 1060	± 313 18 27
(Base-max)a  P < .0001 P < .0001
Colonic water 
content	(mL)
Baseline 0	(0) 0	(0) * * 0.85 0.7 0.93 <0.001
Maximum 538	±	278 540 ± 242 29 48
(Base-Max)b  P = .0005 P = .0005
Content	mixing	
AC	(%)
Baseline 18	±	8 16	±	6 14 41 0.76 0.49 0.89 <0.001
Maximum 35 ± 10 30 ±	7 13 27
(Base-max)a  P < .0001 P < .0001
Content	mixing	
DC	(%)
Baseline 23 ±	8 22 ±	7 15 33 0.62 0.3 0.81 <0.001
Maximum 31 ± 11 28	±	7 16 29
(Base-max)a  P =	.0106 P =	.0177
Wall	movement	
AC	(a.u)























95	(95-113) 90	(51-133) 110 19 0.98 0.94 0.99 <0.001




*CoV unable to be calculated due to the large number of zero data. 
†Further	segmented	data	in	Tables	S1	and	S2.	
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2.5 | Image analysis





ness was increased to 5.4 mm by averaging three consecutive slices 
to reduce the number of images to be used in the analysis from 111 to 
37.	Colonic	content	mixing	within	the	colon	was	assessed	using	the	
average	coefficient	of	variance	(%)	for	the	colonic	region	of	interest	
in	the	tagged	cine	MRI	data.17 This was calculated from mean and 
standard	deviation	maps	of	the	voxel	intensities	measured	across	the	
time	series	cine	data,	with	a	user-defined	region	of	 interest	drawn	
round the colon contents on the mean intensity map.
For	 the	 colonic	wall	movements,	 the	untagged	 cine	data	were	
non-linearly	 registered	 across	 the	 time	 course	 using	 GIQuant® 
(Motilient	 Ltd).18	 The	 spatio-temporal	 motility	 technique	 (STMM)	
was then used to assess changes in luminal diameter with time 
(due	to	contractions)	along	the	AC	and	DC	using	software	written	
in	Matlab,19,20 and these data were used to calculate the combined 
velocity	distance	motility	index	(a.u.).20	Briefly,	the	speed	of	the	wall	
F I G U R E  3  Bland-Altman	plots	showing	difference	vs	average	with	dotted	lines	representing	bias	and	95%	limits	of	agreement,	and	a	
paired t	test	or	Wilcoxon	test	(if	non-normal	data)	used	to	assess	for	significance	of	this	bias
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F I G U R E  4  Correlation	all	endpoints	at	baseline	and	maximum,	with	line	of	identity	shown,	visit	1	vs	visit	2
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motion was multiplied with the normalized luminal diameter changes 





Basic	 characteristics	 of	 the	 study	 population	 were	 summarized	
using	 frequencies,	 percentages,	means	 and	 standard	deviations	 as	
appropriate.	The	maximum	value	after	 the	drink	 for	each	MRI	pa-
rameter	was	determined	from	T60	and	T120	data	for	each	subject	
to	allow	 for	 the	 fact	 that	oro-cecal	 transit	 times	of	 the	drink,	 and	




The	 reproducibility	 of	 these	 MRI	 parameters	 (volumes,	 water	
content,	content	mixing	and	wall	movement)	as	well	as	time	to	first	
bowel	 movement	 (TBM)	 was	 determined	 by	 carrying	 out	 Bland-
Altman	 analysis.21	 Coefficients	 of	 variation	 ((Standard	 Deviation/
Mean)	×	100)	 for	 intrasubject	data	and	 ICC	 (using	 two	way	mixed	
models	with	absolute	agreement)	were	calculated	 for	 the	baseline	
and	maximum	values	acquired	by	T = 120 minutes from starting the 
drink,	analyzed	from	the	two	visits.	Intersubject	coefficient	of	vari-
ance data was also assessed to determine whether the intrasubject 
variability was similar to the intersubject variability.
Bland-Altman	plots	were	generated	with	dotted	lines	represent-
ing	bias	and	95%	limits	of	agreement,	and	a	paired	t	test	or	Wilcoxon	
test	 (if	 non-normal	data)	was	used	 to	 assess	 the	 statistical	 signifi-
cance	of	this	bias.	For	ICC,	the	95%	confidence	interval	of	the	ICC	
estimate is used as the basis to evaluate the level of reliability using 
the following general guideline:
Values	less	than	0.5	are	indicative	of	poor	reliability,	
values	 between	 0.5	 and	 0.75	 indicate	moderate	 re-






participants responded to the macrogol stimulus the same way on both 
occasions. This follows the assumption that the baseline data represent 
the no or very low motility state with its inherent measurement error due 
to breathing and positioning of the lines to generate the motility metric. 
A	90%	limit	to	this	baseline	data	would	therefore	give	a	realistic	upper	
limit to the no motility state. Response to stimulus was also tested in all 
MRI	endpoints	at	both	visits	using	either	the	paired	t	test	or	Wilcoxon	
test	of	baseline	and	maximum	values,	to	determine	whether	a	significant	
increase in each endpoint was measured after the macrogol drink.
This was a pilot study to enable us to make power calculations 
for	the	MRI	endpoints	for	future	studies.	Given	the	expense	of	these	
studies,	we	chose	a	sample	size	of	12	which	we	felt	was	a	reasonable	
compromise and has some justification based on rationale around 
feasibility and precision of estimates.23	A	previous	manometry	 re-
producibility study showed good reproducibility in ambulatory ma-









endpoints	 changed	 significantly	 from	baseline	 to	maximum	values	
following	the	macrogol	challenge	(Table	1).
F I G U R E  5  Graph	of	responders/non-responders	for	colonic	wall	movement




to 0.3. The ICC for volumes and water content performed best with 
colonic	volume	ICC	at	0.84,	and	maximum	total	gut	water	content	and	




Bland-Altman	 plots	 are	 shown	 in	 Figure	 3	 for	 the	 maximum	
post-stimulus	 data	 only,	 which	 show	 no	 statistically	 significant	 bias	








in	Figure	5.	This	 shows	 that	 for	 the	AC,	 all	 participants	kept	 their	
responder status and in the DC one participant changed responder 
status across visits.
3.3 | Symptom scores
Symptom	 scores	 for	 abdominal	 pain,	 flatulence	 and	 bloating	were	
all	 low.	 All	 participants	 scored	 zero	 at	 baseline	 for	 all	 symptoms.	
For	 both	 visits	 at	 T60	 and	 T120,	median	 scores	were	 all	<0.5 for 
all symptoms. There was no significant difference found between 
visit 1 and 2 scores for any symptoms at both time points (p values 














shown to be consistent on different occasions24,25;	 however,	 the	
fact	that	these	volume	and	content	mixing	measurements	were	also	
reproducible	 post-stimulus	 suggests	 that	 these	 responses	 are	 rel-









the response of the colon to the stimulus.
AC	and	DC	wall	movement	were	reasonably	repeatable	at	base-
line,	with	a	low	metric	measured	compared	to	the	post-stimulus	data,	
but the response to the challenge was variable between study days 
resulting in a lower ICC overall and indicating variability in the physi-
ological	response	to	the	stimulus,	likely	due	to	the	irregular	nature	of	
colonic contractions following the macrogol drink. It is known from 
manometry	data	that	 in	resting	condition,	colonic	contractions	are	
erratic; a study in healthy volunteers performed over 4 hours found 
that	high	amplitude	contractions	make	up	only	1.4%	of	the	contrac-
tile activity of the colon.26	Simultaneous	detection	of	these	high	am-
plitude	contractions	from	manometry	with	MRI	has	been	previously	
shown	 by	Kirchhoff	 et	 al27 who also showed low motility in their 
basal data prior to bisacodyl instillation in the DC. They also showed 
that	following	the	bisacodyl	not	all	subjects’	colons	produced	high	
amplitude	contractions	during	their	24-minute	measurement	period,	
with some subjects producing multiple contractions and others none 
at	all.	Given	 the	 fact	 that	 the	wall	movement	 scanning	acquisition	
time	was	 just	10	minutes	each	scan	session,	 it	perhaps	 is	not	 that	
surprising that larger variability was found for these data using this 
method.	 The	 contractions	 seen	 in	 the	wall	 of	 the	AC	 and	DC	 fol-
lowing	the	macrogol	drink	are	not	continuous,	but	sporadic	and	will	




colon wall which is probably the main trigger for the wall motion ob-
served. The water content measurements showed there was larger 
variability	of	this	measure,	across	the	two	visits,	compared	to	the	co-
lonic volumes (although individual colonic segments showed larger 
variation	 [Table	 S1])	 and	 colonic	 content	mixing,	 again	 supporting	
the	assumption	of	variable	oro-cecal	transit	of	the	macrogol	to	the	
colon	and	its	subsequent	transport	and	absorption.
However,	 with	 our	 definition	 of	 responder	 (ie,	 those	 whose	
post-stimulus	response	was	greater	than	the	90%	centile	of	baseline	
values	defining	 the	 “no	motility”	 state),	 all	 subjects	kept	 the	 same	
status	for	AC	wall	movements	and	only	one	changed	for	DC	across	
visits.	The	DC	definition	of	responder	was	set	higher	than	the	AC	due	
to larger amounts of movement present during the baseline scan for 
this region of the colon. There is also more susceptibility of the DC to 
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is likely to be used in clinical practice when looking for abnormalities 
in motility in patient populations.




in the scanner itself (or at least did not ask to be taken out the scan-
ner	mid	scan)	which	constrains	the	data	to	 limited	values	and	may	




the uncontrolled variability in baseline values to yield a value which 
is highly reproducible compared to baseline parameters. It could 
be useful as a screening test to determine who would benefit from 
the	more	expensive	and	detailed	MRI	test.	While	our	procedures	at	
present	may	be	too	demanding	for	routine	clinical	use,	we	believe	a	
single scan assessing colonic volume and colonic wall movement at 
60	minutes	could	provide	a	cost-effective	way	of	excluding	colonic	
inertia but this would need testing in a future study that evaluated 




had an impact on the baseline state of the bowel resulting in larger 
variability.	 Equally	 the	 data	 were	 only	 collected	 over	 a	 relatively	
short period (within either breath holds or over 10 minutes for the 
wall	movements),	and	it	 is	possible	that	these	time	periods	are	not	
representative	of	 the	overall	 effect.	 In	 comparison,	 data	 collected	
from	 the	 traditional	manometry	 techniques	 can	 record	 from	2-	 to	
4-hour	up	to	a	24-hour	period;	however,	this	is	impractical	for	MRI	
studies.	Non-dietary	standardization	of	the	baseline	condition	was	
carried	 out	 (only	 fasting	 and	 restricting	 exercise,	 alcohol	 and	 caf-
feine	consumption)	due	to	impracticalities	of	undertaking	a	dietary	
approach in clinical practice. Variable transit times of constipation 
patients would mean that dietary interventions prior to the scan day 
may	influence	some	patients	more	than	others.	In	addition,	request-
ing defecation prior to starting the scanning would be of limited 
use as almost all of the constipation patients would not be able to 
comply.	Some	of	the	variability	seen	in	the	measurements	may	have	
come	from	intra-observer	variability	in	the	analyses	of	the	data.	This	





server and interobserver variations will be an important determinant 
for	the	use	of	the	individual	MRI	parameters	in	future	studies	and	as	
a clinical test and will be investigated in future studies. The dose of 
macrogol drink was adjusted to subject weight because of our prior 
experience	 that	smaller	people	could	not	 tolerate	 the	 full	1	L.	We	
felt that habitual intake would be proportional to weight rather than 
height,	and	hence,	tolerance	also	affected	by	weight.	In	any	event,	
the doses chosen were well tolerated with median abdominal pain 
and bloating <0.5	on	our	0-3	scale,	but	acknowledge	this	approach	





constipation.	 More	 data	 are	 needed	 to	 better	 define	 the	 normal	
range	for	comparison	with	patient	groups	who	may	have	both	hypo-	
and	hypermotile	responses	to	the	challenge	drink,	and	the	reproduc-
ibility of the test in patients will also need investigating.
We	anticipate	 that	 this	 test	 could	 be	 of	 value	 by	 providing	 an	
objective measure of responsiveness of the colon to the macrogol 
stimulus. It may be particularly valuable in showing that the colon is 
not inert in patients who are dissatisfied with their response to stan-
dard therapies. This would be of value in the work up of patients in 
whom colectomy is being considered and encourage a more vigorous 
search for behavioral abnormalities like pelvic dyssynergia or eating 
disorders which can be missed in routine care.
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